KR20080019014A - 키토산 및 사이클로덱스트린을 포함하는 나노입자 - Google Patents

키토산 및 사이클로덱스트린을 포함하는 나노입자 Download PDF

Info

Publication number
KR20080019014A
KR20080019014A KR1020077029819A KR20077029819A KR20080019014A KR 20080019014 A KR20080019014 A KR 20080019014A KR 1020077029819 A KR1020077029819 A KR 1020077029819A KR 20077029819 A KR20077029819 A KR 20077029819A KR 20080019014 A KR20080019014 A KR 20080019014A
Authority
KR
South Korea
Prior art keywords
cyclodextrin
chitosan
nanoparticles
biologically active
active molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020077029819A
Other languages
English (en)
Korean (ko)
Inventor
엠에이 호세 알론소 페르난데스
마르코스 가르시아 푸엔테스
프란세스카 마에스트렐리
파올라 무라
Original Assignee
유니버시다데 데 산티아고 데 콤포스텔라
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유니버시다데 데 산티아고 데 콤포스텔라 filed Critical 유니버시다데 데 산티아고 데 콤포스텔라
Publication of KR20080019014A publication Critical patent/KR20080019014A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020077029819A 2005-06-02 2006-06-01 키토산 및 사이클로덱스트린을 포함하는 나노입자 Ceased KR20080019014A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP200501331 2005-06-02
ES200501331A ES2277743B2 (es) 2005-06-02 2005-06-02 Nanoparticulas que comprenden quitosano y ciclodextrina.

Publications (1)

Publication Number Publication Date
KR20080019014A true KR20080019014A (ko) 2008-02-29

Family

ID=37482018

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077029819A Ceased KR20080019014A (ko) 2005-06-02 2006-06-01 키토산 및 사이클로덱스트린을 포함하는 나노입자

Country Status (11)

Country Link
US (1) US20080220030A1 (https=)
EP (1) EP1891943A2 (https=)
JP (1) JP5191884B2 (https=)
KR (1) KR20080019014A (https=)
CN (1) CN101217947B (https=)
AU (1) AU2006254128A1 (https=)
BR (1) BRPI0613234A2 (https=)
CA (1) CA2610403A1 (https=)
ES (1) ES2277743B2 (https=)
IL (1) IL187696A0 (https=)
WO (1) WO2006128937A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102034982B1 (ko) * 2019-03-08 2019-10-21 주식회사 제론바이오 Pdrn이 캡슐화된 키토산 나노 입자가 포함된 점안제 및 이의 제조 방법
KR102172667B1 (ko) * 2020-02-05 2020-11-02 이채현 덱스트린 글루코노 락톤 술폰 유도체의 제조 방법 및 약제학적 조성물 이를 이용한 동물, 인간, 어류 등의 바이러스 질환 예방 및 치료제

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2310122B1 (es) * 2007-04-20 2009-10-30 Instituto Cientifico Y Tecnologico De Navarra, S.A Nanoparticulas que comprenden una ciclodextrina y una molecula biologicamente activa y sus aplicaciones.
US20110064664A1 (en) * 2007-10-08 2011-03-17 The Board Of Regents Of The University Of Texas System Methods and compositions involving chitosan nanoparticles
UA90013C2 (ru) * 2008-03-19 2010-03-25 Давид Анатолійович Нога Фармацевтическая композиция, содержащая инсулин, и способ его получения
TWI328565B (en) * 2008-12-19 2010-08-11 Taiwan Textile Res Inst Dispersions of conductive carbon materials and methods for preparing the same
JP5841044B2 (ja) * 2009-03-23 2016-01-06 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． 複合糖質ワクチン
JP5804453B2 (ja) * 2009-05-14 2015-11-04 国立大学法人 東京大学 結晶性ポリオール微粒子及びその調製方法
CN102481360B (zh) * 2009-06-25 2015-06-17 生物领先公司 包含聚γ谷氨酸-壳聚糖纳米颗粒的佐剂组合物
US8372877B2 (en) 2010-04-16 2013-02-12 Cumberland Pharmaceuticals Stabilized statin formulations
CN102008450B (zh) * 2010-12-10 2013-01-30 杭州艾瑞莎生物医药科技有限公司 一种药物-环糊精纳米颗粒及其制备方法
CN102416000B (zh) * 2011-12-13 2013-04-10 张维芬 一种用于肺吸入的壳聚糖季铵盐大孔微球及其制备方法
FR2989001B1 (fr) * 2012-04-06 2017-07-21 Centre Nat Rech Scient Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine
CN102908315B (zh) * 2012-11-02 2014-06-04 上海现代药物制剂工程研究中心有限公司 小分子干扰核糖核酸的壳聚糖纳米粒传递系统及制备方法
JP2016510001A (ja) * 2013-02-21 2016-04-04 マサチューセッツ インスティテュート オブ テクノロジー シスプラチン充填キトサンナノ粒子を含む標的化された頬側送達
FR3006315B1 (fr) 2013-05-31 2015-10-02 Centre Nat Rech Scient Microparticules et nanoparticules auto-associatives composees de proteines
FR3011470B1 (fr) * 2013-10-09 2017-01-06 Centre Nat De La Rech Scient (Cnrs) Composition antifongique comprenant un agent antifongique et du chitosane hydrophobise
US20160046732A1 (en) * 2014-08-15 2016-02-18 Empire Technology Development Llc Aseptic polymeric compositions and methods of using the same
WO2016066864A1 (es) 2014-10-30 2016-05-06 Innovaciones Fisicas Y Quimicas Sostenibles, S.L. Nanopartículas para la liberación controlada de ingredientes activos
CN104738815B (zh) * 2015-02-11 2018-01-30 浙江中烟工业有限责任公司 一种降低卷烟烟气中苯酚的纳米环糊精复合添加剂及其制备方法和应用
CN104720108B (zh) * 2015-02-11 2018-01-30 浙江中烟工业有限责任公司 一种纳米环糊精复合添加剂及其制备方法和应用
CA3015172A1 (en) 2016-02-18 2017-08-24 Privo Technologies, Inc. Two-stage microparticle-based therapeutic delivery system and method
WO2018081291A1 (en) * 2016-10-25 2018-05-03 Washington University Nanoparticle compositions comprising cd38 and methods of use thereof
CN106822914A (zh) * 2017-01-10 2017-06-13 安徽师范大学 一种羧甲基‑β‑环糊精接枝壳聚糖离子交联纳米粒、制备方法及其应用
WO2018151849A1 (en) 2017-02-17 2018-08-23 Privo Technologies, Inc. Particle-based multi-layer therapeutic delivery device and method
US10478403B1 (en) 2017-05-03 2019-11-19 Privo Technologies, Inc. Intraoperative topically-applied non-implantable rapid release patch
US11623202B2 (en) * 2017-05-18 2023-04-11 Agency For Science, Technology And Research Composite structure and method of forming the same
US20200338011A1 (en) * 2017-10-20 2020-10-29 The General Hospital Corporation Macrophage Targeted Immunotherapeutics
CN110522921A (zh) * 2018-05-24 2019-12-03 广东省医疗器械研究所 一种具有胰岛素捕获功能的胰岛素输运体系的合成方法
CN108849995B (zh) * 2018-06-12 2020-06-30 甘肃省科学院生物研究所 黄帚橐吾提取物纳米杀虫剂及其制备方法
CN109012629B (zh) * 2018-08-16 2021-07-30 南京大学 一种制备磁性羧甲基β-环糊精聚合物的方法及其应用
CN109908367A (zh) * 2019-04-30 2019-06-21 南开大学 磺胺酸-β-环糊精介导的超分子纳米粒子在胰岛素的控制释放方面的应用
CN110384684B (zh) * 2019-08-26 2021-04-06 安徽农业大学 一种单羧基壳聚糖/紫草素复合纳米颗粒及其制备方法
KR102904096B1 (ko) * 2019-12-06 2025-12-24 (주) 에이치엔에이파마켐 공유결합성 유기 골격체 및 폴리머를 이용한 경피전달용 복합체
JP7319931B2 (ja) * 2020-01-22 2023-08-02 オリエンタル酵母工業株式会社 キトサン部分分解物の安定化方法、キトサン部分分解物の保存方法および食品用保存剤
CN111437381B (zh) * 2020-02-13 2023-12-12 汕头大学 一种水凝胶微粒及其制备方法
CN112843336B (zh) * 2021-03-04 2022-10-25 首都医科大学 一种促进牙本质再生的纳米颗粒、凝胶及其制备方法和应用
KR20240041285A (ko) 2021-06-01 2024-03-29 프리보 테크놀로지스, 인코포레이티드 향상된 2단계 미세입자 기반 국소 치료제 전달 시스템
CN113773161B (zh) * 2021-10-12 2022-12-09 龙蟒大地农业有限公司 一种圆颗粒钾肥及其制备方法
CN113995834A (zh) * 2021-11-08 2022-02-01 江南大学 一种基于环糊精接枝壳聚糖的疫苗、制备方法及应用
CN114176157A (zh) * 2021-11-15 2022-03-15 安佑生物科技集团股份有限公司 一种抑制畜禽球虫的绿色添加剂、制备方法及应用
CN114904493B (zh) * 2022-03-31 2024-09-06 中科院广州化学有限公司 一种离子交联β-环糊精聚合物及其制备方法与应用
CN114451426B (zh) * 2022-04-13 2022-07-15 山东健源生物科技有限公司 用于畜禽环境改良的消毒抑菌生物复合制剂及其制备方法
CN115595809A (zh) * 2022-10-25 2023-01-13 东莞市伊时针织印花有限公司（Cn） 一种用于蛋白质纤维织物的酸性染料及其制备方法
AU2023420130A1 (en) * 2022-12-30 2025-08-14 Cornell University Acid cyclodextrins for the treatment of lipofuscin buildups and ocular diseases
CN116515147A (zh) * 2023-05-24 2023-08-01 江南大学 一种拓扑型环糊精/壳聚糖复合膜及其制备方法与应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US619757A (en) 1899-02-21 Knockdown or collapsible box
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
DE59107006D1 (de) * 1990-04-25 1996-01-18 Hoechst Ag Pharmakologische Zubereitung, enthaltend Polyelektrolytkomplexe in mikropartikulärer Form und mindestens einen Wirkstoff.
IT1246188B (it) 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
CN1037232C (zh) * 1992-09-04 1998-02-04 付伟 β-常温保鲜剂
NZ262679A (en) 1993-02-22 1997-08-22 Vivorx Pharmaceuticals Inc Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
US5843347A (en) * 1993-03-23 1998-12-01 Laboratoire L. Lafon Extrusion and freeze-drying method for preparing particles containing an active ingredient
US5849327A (en) * 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
GB9416884D0 (en) * 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
JP3699141B2 (ja) 1994-09-24 2005-09-28 伸彦 由井 超分子構造の生体内分解性医薬高分子集合体及びその調製方法
US5686113A (en) * 1995-03-21 1997-11-11 Temple University Of The Commonwealth System Of Higher Education Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses
WO1997004747A1 (en) 1995-07-27 1997-02-13 Dunn James M Drug delivery systems for macromolecular drugs
ES2114502B1 (es) * 1996-07-29 1999-07-01 Univ Santiago Compostela Aplicacion de nanoparticulas a base de polimeros hidrofilicos como formas farmaceuticas.
US6649192B2 (en) 1996-07-29 2003-11-18 Universidade De Santiago De Compostela Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms
GB9711643D0 (en) * 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
DE69921773D1 (de) * 1998-01-16 2004-12-16 Univ Johns Hopkins Orale verabreichung von nukleinsäure-impstoffen durch partikelkomplexe
WO1999061062A1 (en) 1998-05-29 1999-12-02 Massachusetts Institute Of Technology Cyclodextrin complexes
US6630169B1 (en) 1999-03-31 2003-10-07 Nektar Therapeutics Particulate delivery systems and methods of use
TR200103613T2 (tr) 1999-06-16 2004-08-23 Nastech Pharmaceutical Co., Inc. Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.
US7030097B1 (en) * 1999-07-14 2006-04-18 Cornell Research Foundation, Inc. Controlled nucleic acid delivery systems
HU229705B1 (en) * 2000-02-08 2014-05-28 Euro Celtique Sa Tamper-resistant oral opioid agonist formulations
US6497901B1 (en) 2000-11-02 2002-12-24 Royer Biomedical, Inc. Resorbable matrices for delivery of bioactive compounds
JP4593846B2 (ja) * 2001-09-07 2010-12-08 信越化学工業株式会社 医薬品又は食品用マイクロカプセルの製造方法
FR2830017B1 (fr) 2001-09-27 2005-11-04 Centre Nat Rech Scient Materiau compose d'au moins un polymere biodegradable et de cyclodextrines
JP3908969B2 (ja) * 2002-03-18 2007-04-25 ピアス株式会社 化粧料
FR2841137B1 (fr) * 2002-06-20 2004-08-13 Bioalliance Pharma Systeme de vectorisation comprenant des nanoparticules de taille homogene d'au moins un polymere et d'au moins un polysaccharide charge positivement
FR2842106B1 (fr) * 2002-07-11 2006-07-14 Centre Nat Rech Scient Dispersions aqueuses de particules nanometriques ou micrometriques pour l'encapsulation de composes chimiques
CN1255433C (zh) * 2002-10-15 2006-05-10 浙江大学 壳聚糖－β－环糊精树脂的制备方法
WO2004096998A2 (en) * 2003-04-29 2004-11-11 Vanderbilt University Nanoparticular tumor targeting and therapy
JP4747256B2 (ja) * 2003-11-04 2011-08-17 Ｊｎｃ株式会社 複合刺激応答材料

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102034982B1 (ko) * 2019-03-08 2019-10-21 주식회사 제론바이오 Pdrn이 캡슐화된 키토산 나노 입자가 포함된 점안제 및 이의 제조 방법
WO2020184916A1 (ko) * 2019-03-08 2020-09-17 주식회사 제론바이오 Pdrn이 캡슐화된 키토산 나노 입자가 포함된 점안제 및 이의 제조 방법
US12427107B2 (en) 2019-03-08 2025-09-30 Zerone Bio Inc. Eye drops containing chitosan nanoparticles in which PDRN is encapsulated, and preparation method therefor
KR102172667B1 (ko) * 2020-02-05 2020-11-02 이채현 덱스트린 글루코노 락톤 술폰 유도체의 제조 방법 및 약제학적 조성물 이를 이용한 동물, 인간, 어류 등의 바이러스 질환 예방 및 치료제

Also Published As

Publication number Publication date
CN101217947A (zh) 2008-07-09
ES2277743B2 (es) 2008-12-16
ES2277743A1 (es) 2007-07-16
AU2006254128A1 (en) 2006-12-07
EP1891943A2 (en) 2008-02-27
WO2006128937A3 (es) 2007-02-15
JP2008542342A (ja) 2008-11-27
JP5191884B2 (ja) 2013-05-08
CA2610403A1 (en) 2006-12-07
US20080220030A1 (en) 2008-09-11
CN101217947B (zh) 2012-04-25
WO2006128937A2 (es) 2006-12-07
BRPI0613234A2 (pt) 2010-12-28
IL187696A0 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
KR20080019014A (ko) 키토산 및 사이클로덱스트린을 포함하는 나노입자
Singh et al. Alginate based nanoparticles and its application in drug delivery systems
Hudson et al. Biopolymer nanoparticle production for controlled release of biopharmaceuticals
He et al. Polyethyleneimine/DNA polyplexes with reduction-sensitive hyaluronic acid derivatives shielding for targeted gene delivery
JP2009537604A (ja) 活性分子の投与のためのキトサンおよびヒアルロナンのナノ粒子
JP4651192B2 (ja) 少なくとも一つの重合体および一つ又は複数の有効成分と複合体を形成できる少なくとも一つの化合物から成るナノ粒子およびその製造方法
JP5542687B2 (ja) ヒアルロン酸誘導体、およびその医薬組成物
EP2366386A1 (en) Nanoparticulate systems prepared from anionic polymers
US20100092572A1 (en) Chitosan-based colloidal particles for rna delivery
US20060148756A1 (en) Amphiphilic macrocyclic derivatives and their analogues
JP2002504526A5 (https=)
Xiong et al. Auricularia auricular polysaccharide-low molecular weight chitosan polyelectrolyte complex nanoparticles: Preparation and characterization
CN106456454A (zh) 用于包封和释放生物活性大分子的可崩解核/壳二氧化硅颗粒
Li et al. Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin
Guido et al. Capsid-like biodegradable poly-glycolic acid nanoparticles for a long-time release of nucleic acid molecules
CN101448489A (zh) 用于活性分子给药的壳聚糖和乙酰透明质酸的纳米颗粒
Jana et al. Nanoengineering of biomaterials: Drug delivery & biomedical applications
Leyva-Gómez et al. Natural polymers in pharmaceutical nanotechnology
Song et al. Preparation and evaluation of insulin-loaded nanoparticles based on hydroxypropyl-β-cyclodextrin modified carboxymethyl chitosan for oral delivery
Hooda et al. Chitosan nanoparticles: A marine polysaccharide for biomedical research
Pérez-Álvarez et al. Chitosan-based nanogels for biomedical applications
Konovalova et al. Development of mucoadhesive chitosan-based drug delivery system
Kapadnis et al. Chitosan Oligosaccharides: Drug and Gene Delivery
Oh DEVELOPMENT OF NANOCARRIERS WITH ENHANCED STABILTIY AND TRANSFECTION EFFICIENCY

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20071220

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20110530

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130311

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20131029

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20140530

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20131029

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 20130311

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I